Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

M Omata, AL Cheng, N Kokudo, M Kudo, JM Lee… - Hepatology …, 2017 - Springer
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

[HTML][HTML] Predictors of early and late hepatocellular carcinoma recurrence

R Nevola, R Ruocco, L Criscuolo, A Villani… - World journal of …, 2023 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi …

LQ Yao, ZL Chen, ZH Feng, YK Diao, C Li… - Annals of surgical …, 2022 - Springer
Background A potentially curative hepatic resection is the optimal treatment for
hepatocellular carcinoma (HCC), but most HCCs, even at an early stage, eventually recur …

Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery

S Shiina, K Sato, R Tateishi, M Shimizu… - Canadian Journal of …, 2018 - Wiley Online Library
Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …

Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma

V Granata, R Grassi, R Fusco, A Belli, C Cutolo… - Infectious Agents and …, 2021 - Springer
This article provides an overview of diagnostic evaluation and ablation treatment
assessment in Hepatocellular Carcinoma (HCC). Only studies, in the English language from …

A review of radiofrequency ablation: Large target tissue necrosis and mathematical modelling

B Zhang, MAJ Moser, EM Zhang, Y Luo, C Liu… - Physica Medica, 2016 - Elsevier
Radiofrequency ablation (RFA) is an effective clinical method for tumour ablation with
minimum intrusiveness. However, the use of RFA is mostly restricted to small tumours …

Neoadjuvant and adjuvant systemic therapies in loco-regional treatments for hepatocellular carcinoma: are we at the dawn of a new era?

R Nevola, A Delle Femine, V Rosato, LA Kondili… - Cancers, 2023 - mdpi.com
Simple Summary The treatment of hepatocellular carcinoma is burdened by an
unacceptable recurrence rate after loco-regional treatment. Unlike all other solid tumors, no …

Efficacy of hepatic resection vs. radiofrequency ablation for patients with very-early-stage or early-stage hepatocellular carcinoma: a population-based study with …

YQ Jiang, ZX Wang, YN Deng, Y Yang… - Frontiers in …, 2019 - frontiersin.org
Background: Because of the poor health conditions of elderly patients (age> 65) with very-
early-stage and early-stage hepatocellular carcinoma (HCC), primary treatment via hepatic …

[HTML][HTML] Preoperative albumin-bilirubin score for postoperative solitary hepatocellular carcinoma within the milan criteria and Child-Pugh A cirrhosis

ZR Dong, J Zou, D Sun, GM Shi, AW Ke, JB Cai… - Journal of …, 2017 - ncbi.nlm.nih.gov
Surgical resection remains the initial treatment of choice for the majority of early stage
hepatocellular carcinoma (HCC) patients. Although the factors that influence the prognosis …

Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma≤ 5 cm without cirrhosis: A population-based study with …

SC Dong, DS Bai, FA Wang, SJ Jin, C Zhang… - … & Pancreatic Diseases …, 2023 - Elsevier
Abstract Background About 10%-20% of all individuals who develop hepatocellular
carcinoma (HCC) do not have cirrhosis. Comparisons are rarely reported regarding the …